Rubicon Research is an Indian pharmaceutical company located in Mumbai.
The company has its corporate headquarters and R&D center in Thane, India, an R&D center in Concord, Canada, manufacturing plants located in Ambernath, Satara and Pithampur, India, and a regulatory office in East Windsor, US.
History
Rubicon Research was founded in 1999 by Pratibha Pilgaonkar, Sudhir Pilgaonkar, and Maharukh Rustomjee. In 2000 it started operations as an independent product development company, located in Bhandup, Mumbai, with three scientists in a 2000 sqft laboratory. It became an outsourcing partner to the global healthcare and pharmaceutical industry. In 2003, the Directorate of Science and Technology, Government of India approved the facilities as a commercial Research and Development (R&D) company.
In 2006-07 Rubicon licensed its Orodispersible excipient, RubiODT to Mallinckrodt Baker, Inc.[1]
In 2009 the company commission an oral solids manufacturing plant in Ambernath, India. Rubicon Research started its commercial manufacturing and shipments to the US and Europe in 2015.
In 2012 Rubicon Research signed an agreement with Avantor Performance Materials to develop and market a novel gastro-retentive excipient that enables the delivery of molecules with a window of absorption.[2]